Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tailoring of medical treatment: hemostasis and thrombosis towards precision medicine.

Literature DB >> 28250003

Tailoring of medical treatment: hemostasis and thrombosis towards precision medicine.

Giovanni Di Minno¹, Elena Tremoli².

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2017 PMID： 28250003 PMCID： PMC5394976 DOI： 10.3324/haematol.2016.156000

Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941

× No keyword cloud information.

79 in total

Review 1. The hope and reality of long-acting hemophilia products.

Authors: Steven W Pipe
Journal: Am J Hematol Date: 2012-03-03 Impact factor: 10.047

2. Public Health in the Precision-Medicine Era.

Authors: Ronald Bayer; Sandro Galea
Journal: N Engl J Med Date: 2015-08-06 Impact factor: 91.245

3. PharmGKB: a logical home for knowledge relating genotype to drug response phenotype.

Authors: Russ B Altman
Journal: Nat Genet Date: 2007-04 Impact factor: 38.330

4. Cardiovascular precision medicine: hope or hype?

Authors: Geoffrey S Pitt
Journal: Eur Heart J Date: 2015-06-14 Impact factor: 29.983

Review 5. Lessons from the cancer genome.

Authors: Levi A Garraway; Eric S Lander
Journal: Cell Date: 2013-03-28 Impact factor: 41.582

6. Clopidogrel non-responsiveness and risk of cardiovascular morbidity. An updated meta-analysis.

Authors: Francesco Sofi; Rossella Marcucci; Anna Maria Gori; Betti Giusti; Rosanna Abbate; Gian Franco Gensini
Journal: Thromb Haemost Date: 2010-02-02 Impact factor: 5.249

7. PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes.

Authors: Jessica L Mega; Sandra L Close; Stephen D Wiviott; Michael Man; Suman Duvvuru; Joseph R Walker; Scott S Sundseth; Jean-Philippe Collet; Jessica T Delaney; Jean-Sebastien Hulot; Sabina A Murphy; Guillaume Paré; Matthew J Price; Dirk Sibbing; Tabassome Simon; Dietmar Trenk; Elliott M Antman; Marc S Sabatine
Journal: J Thromb Thrombolysis Date: 2016-04 Impact factor: 2.300

Review 2. Challenges in Metabolomics-Based Tests, Biomarkers Revealed by Metabolomic Analysis, and the Promise of the Application of Metabolomics in Precision Medicine.

Authors: Alessandro Di Minno; Monica Gelzo; Marianna Caterino; Michele Costanzo; Margherita Ruoppolo; Giuseppe Castaldo
Journal: Int J Mol Sci Date: 2022-05-06 Impact factor: 6.208

2 in total

Tailoring of medical treatment: hemostasis and thrombosis towards precision medicine.

Review 1. The hope and reality of long-acting hemophilia products.

2. Public Health in the Precision-Medicine Era.

3. PharmGKB: a logical home for knowledge relating genotype to drug response phenotype.

4. Cardiovascular precision medicine: hope or hype?

Review 5. Lessons from the cancer genome.

6. Clopidogrel non-responsiveness and risk of cardiovascular morbidity. An updated meta-analysis.

7. PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes.

8. Opportunities for the Cardiovascular Community in the Precision Medicine Initiative.

Review 9. Variability in responsiveness to oral antiplatelet therapy.

Review 10. Economic Benefits of Investing in Women's Health: A Systematic Review.

1. Prophylaxis of venous thromboembolism in Internal Medicine Units: the RAMs issue.

Review 2. Challenges in Metabolomics-Based Tests, Biomarkers Revealed by Metabolomic Analysis, and the Promise of the Application of Metabolomics in Precision Medicine.